Sakabe Koichi, Fukuda Nobuo, Wakayama Katsunori, Nada Teru, Shinohara Hisanori, Tamura Yoshiyuki
Department of Cardiology and Clinical Research, National Zentsuji Hospital, 2-1-1 Senyu-cho, Zentsuji, Kagawa 765-8507, Japan.
Am J Cardiol. 2004 Aug 15;94(4):497-500. doi: 10.1016/j.amjcard.2004.04.067.
In this prospective study, we found beneficial short-term effects from atorvastatin therapy, including effects on low-density lipoprotein subfractions and remnant-like lipoprotein particle cholesterol, antioxidant effects, and alterations in endothelial function that may be important in early benefit from statin therapy; some effects would support much earlier benefit than previously reported. We also found long-term effects of atorvastatin, including decreased plasminogen activator inhibitor type-1 and additional significant alterations in low-density lipoprotein subfractions and endothelial function, supporting benefits from continuous long-term atorvastatin therapy beyond early reversal of hypercholesterolemia.
在这项前瞻性研究中,我们发现阿托伐他汀治疗具有有益的短期效果,包括对低密度脂蛋白亚组分和残粒样脂蛋白颗粒胆固醇的影响、抗氧化作用以及内皮功能的改变,这些改变可能对他汀类药物治疗的早期获益很重要;一些效果表明获益时间比先前报道的要早得多。我们还发现了阿托伐他汀的长期效果,包括纤溶酶原激活物抑制剂-1水平降低以及低密度脂蛋白亚组分和内皮功能的其他显著改变,这支持了持续长期使用阿托伐他汀治疗除早期逆转高胆固醇血症之外的益处。